Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and Rechallenge

Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and Rechallenge

<b>Background</b>: The treatment landscape for non-small cell lung cancer (NSCLC) has evolved significantly with the advent of immunotherapy. Nonetheless, uncertainty regarding optimal first-line treatments, special populations, and the feasibility of rechallenge remains. This study aims...

Full description

Bibliographic Details
Main Authors: Francesca Colonese, Alessandra Bulotta, Carlo Genova, Diego Signorelli, Laura Bonanno, Claudia Proto, Immunotherapy in NSCLC Delphi Panel, Diego Luigi Cortinovis
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Biomedicines
Subjects:
non-small-cell lung cancer
immunotherapy
Delphi survey
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/2227-9059/12/12/2742

Internet

https://www.mdpi.com/2227-9059/12/12/2742

Similar Items